• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Hospital Acquired Infections: Testing Markets

$3,995.00 – $7,990.00

Clear
SKU: KLI4861606 Categories: Healthcare Facilities & Settings, Healthcare Market Research Pages: 117
  • Description
  • Table of Contents
  • Latest reports

Description

A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). The following are among the hospital infections considered in this report:

  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Tuberculosis
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Ventilator-Associated Pneumonia

This report focuses on testing for nosocomial infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medial considerations and on market considerations. This report Hospital Acquired Infection Testing Markets looks at the market for diagnostics that address the growing nosocomial infection threat. As part of its coverage, the report includes the following information:

  • Market Size Estimate and Growth Forecast for the HAI Diagnostics Market
  • Issues and Trends Affecting Market
  • Common Hospital (nosocomial) Infections
  • Nosocomial Infection Statistics
  • International Hospital Length of Stay Statistics
  • The Role of Molecular Tests vs. Traditional
  • Corporate Profiles of Key Suppliers

Market analysis in this report considers primarily the epidemiological considerations and the sizes patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing and treatment needs.

The primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for diagnosing these infections. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

Companies Profiled in the report include the following:

  • Abbott Laboratories
  • Alere
  • Becton, Dickinson
  • bioMerieux
  • Cephei
  • Gen-Probe
  • Meridian Bioscience, Inc.
  • Qiagen GmbH
  • Roche
  • Siemens AG

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • Infection Control Summary
  • Scope and Methodology
  • Total Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS

  • Overview
    • Introduction to Pathogens
    • Classification of Antibacterial Organisms
    • Common Hospital (nosocomial) Infections
  • Hospital Units and Infection Risks
    • Burn Units
    • Intensive Care Units
    • Emergency Departments
    • General Infection Statistics
    • Nosocomial Infection Statistics
    • Hospital Length of Stay
    • Populations at Risk for Infection
  • Demographics of the World
    • Life Expectancy
  • Economic Trends
    • Comparison Between Healthcare Spending and Real Health Outcomes
  • Infections and Drug Resistance
    • Causes of Drug Resistance
    • Drug Resistance in Select Populations
    • Measures for Reducing Resistance
    • Screening Hospitalized patients
  • Prevention Measures
    • Potential Use of Copper for Reducing Infection
    • Wide Area Disinfection Methods
    • Software for Infection Detection and Control
  • The American Recovery and Reinvestment Act of 2009
    • U.S. Statewide Standardized Infection Ratio
    • State Level Case Study of HAI Admissions and Readmissions
    • John T. Mather Memorial Hospital/Cepheid-Case Study
  • Manufacturer and Marketer Trends
    • Trends in Partnerships and Alliances
    • Developers Trends

CHAPTER THREE: HOSPITAL INFECTION TESTING PRODUCTS

  • OverviewMethods of TransmissionTesting Methods
    • Drug-Resistance/Susceptibility Testing
    • Genotypic Methods
  • Specific Nosocomial Disease Testing
    • Acinetobacter Baumannii
    • Clostridium Difficile
    • Hospital-Acquired Pneumonia
    • Pseudomonas Aeruginosa
    • Staphylococcus Aureus
    • Tuberculosis
    • Urinary Tract Infections
    • Vancomycin-resistant Enterococcus
    • Ventilator-Associated Pneumonia
  • New Developments

CHAPTER FOUR: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION TESTING

  • Market Considerations
  • Market Overview
  • Total Market Size and Forecast
    • Hospital Infection Testing Market by Geographical Region
  • Competitive Analysis

CHAPTER FIVE: COMPANY PROFILES

  • Introduction
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson
  • bioMerieux
  • Cephei
  • Gen-Probe
  • Meridian Bioscience, Inc.
  • Qiagen GmbH
  • Roche
  • Siemens AG

APPENDIX: LIST OF MAJOR PROVIDERS

 

LIST OF EXHIBITS

 

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Frequency of the Most Common Nosocomial Infections
  • Table 1-2: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 1-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS

  • Table 2-1: Burn Statistics
  • Figure 2-1: U.S. Hospital Admissions and Percent of Hospital-acquired Infections (HAIs)
  • Table 2-2: U.S. Hospital Length of Stay, Average by Age Group
  • Table 2-3: Average International Length of Stay, by Country 2010
  • Table 2-4: World Population at Risk for Serious Bacterial Infections,Secondary to Chronic Diseases by Selected Geographical Region, 2010
  • Figure 2-2: World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2010
  • Table 2-5: Estimated World Population by Age and Geographical Region, 2010
  • Figure 2-3: Estimated World Population by Age and Geographical Region, 2010
  • Table 2-6: Average Life Expectancy in Years by Country 1980, 2004 and 2011
  • Figure 2-4: Average Life Expectancy in Years by Country 1980 and 2011
  • Table 2-7: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2010
  • Figure 2-5: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2010
  • Table 2-8: Healthcare Spending, Obesity and Life Expectancy, 2011
  • Table 2-9: U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR)
  • Table 2-10: Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009
  • Table 2-11: Pennsylvania State Analysis of HAIs, 2009

CHAPTER THREE: HOSPITAL INFECTION TESTING PRODUCTS

  • Table 3-1: Recent Approvals for Hospital Infection Testing
  • Table 3-2: New Developments, Hospital Infection Testing, as of July 2012

CHAPTER FOUR: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION TESTING

  • Table 4-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 4-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 4-2: The World Market for Hospital InfectionTesting/Diagnostics Estimated Market Share by Test Indication, 2011
  • Table 4-2: The World Market for Hospital Infection Testing/Diagnostics Estimated Products Sales by Geographic Region 2007-2016
  • Figure 4-3: The World Market for Hospital Infection Testing/Diagnostics Estimated Product Sales by Geographic Region 2007-2016
  • Figure 4-4: The World Market for Hospital Infection Testing/Diagnostics Estimated Market Share by Region, 2011
  • Table 4-3: The World Market for Hospital Infection Testing/Diagnostics Leading Suppliers’ Shares Estimates for 2011
  • Figure 4-5: The World Market for Hospital Infection Testing/Diagnostics Leading Suppliers’ Shares Estimates for 2011

 

    Clinical Diagnostics MasterFile
    August 30, 2021
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)
    September 18, 2020
    The Market for Urgent Care Centers
    August 6, 2019
    Retail Clinics 2019 Forecast: Locations, Revenues, Supplier Sales, Trends, Consumer Survey
    November 15, 2018

Related products

  • Placeholder image

    Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)

    $995.00 – $4,200.00
  • Placeholder image

    The Global Market for RFID in Healthcare

    $995.00 – $1,990.00
  • Placeholder image

    Healthcare Opportunities for Food Ingredient Manufacturers

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Home Care Products, 5th Edition

    $2,995.00 – $7,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Epigenetics: Applications for Pharmaceuticals and Diagnostics (Methylation,...Cell Phone-Enabled Diagnostics: mHealth Applications in IVD
Scroll to top